233 related articles for article (PubMed ID: 28737007)
1. Evaluating the efficacy of pentoxifylline in the treatment of oral submucous fibrosis: A meta-analysis.
Liu J; Chen F; Wei Z; Qiu M; Li Z; Dan H; Chen Q; Jiang L
Oral Dis; 2018 Jul; 24(5):706-716. PubMed ID: 28737007
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis.
Rajendran R; Rani V; Shaikh S
Indian J Dent Res; 2006; 17(4):190-8. PubMed ID: 17217216
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of oral submucous fibrosis with "Seagull-nasolabial flap" combined with short-term oral pentoxifylline for preventing relapse.
Kholakiya Y; Jose A; Rawat A; Nagori SA; Jacob S; Roychoudhury A
J Stomatol Oral Maxillofac Surg; 2020 Nov; 121(5):512-516. PubMed ID: 31904528
[TBL] [Abstract][Full Text] [Related]
4. "Introducing Modified Dakkak and Bennett Grading System for Indian Food in Oral Submucous Fibrosis": A Dharwad Study.
Kalkur C; Sattur AP; Guttal KS; Lakshman AR
J Diet Suppl; 2019; 16(2):207-214. PubMed ID: 29624459
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of hyaluronidase combined with corticosteroids in treatment of oral submucous fibrosis: A meta-analysis of randomized controlled clinical trials.
Guo J; Xie H; Mao S; Liang M; Wu H
J Oral Pathol Med; 2020 Apr; 49(4):311-319. PubMed ID: 32145110
[TBL] [Abstract][Full Text] [Related]
6. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.
Saran G; Umapathy D; Misra N; Channaiah SG; Singh P; Srivastava S; Shivakumar S
Indian J Dent Res; 2018; 29(3):303-312. PubMed ID: 29900913
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of medicinal interventions for oral submucous fibrosis: A network meta-analysis.
Rai A; Shrivastava PK; Kumar A; Kumar A; Prasad K; Shakeel S; Ul Haque Z
J Stomatol Oral Maxillofac Surg; 2023 Jun; 124(3):101423. PubMed ID: 36781110
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of curcumin in the treatment of oral submucous fibrosis: a Meta-analysis].
Guo JC; Xie H; Wu H; Tong TJ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Apr; 39(2):195-202. PubMed ID: 33834675
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Therapeutic Efficacy of Different Treatment Modalities in Oral Submucous Fibrosis: A Comparative Study.
Tp B; T AG; Varghese M; Raghavan R; Vm MN; Pius A
J Contemp Dent Pract; 2019 Mar; 20(3):390-394. PubMed ID: 31204333
[TBL] [Abstract][Full Text] [Related]
10. Turmeric in the management of oral submucous fibrosis: A systematic review and meta-analysis.
Rai A; Kumar N; Sharma S; Parveen S; Rasheed A
J Cancer Res Ther; 2021; 17(2):327-335. PubMed ID: 34121673
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline therapy in the management of oral submucous fibrosis.
Mehrotra R; Singh HP; Gupta SC; Singh M; Jain S
Asian Pac J Cancer Prev; 2011; 12(4):971-4. PubMed ID: 21790236
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Oral Pentoxifylline in the Management of Oral Submucous Fibrosis - An Ultrasonographic Study.
Sadaksharam J; Mahalingam S
Contemp Clin Dent; 2017; 8(2):200-204. PubMed ID: 28839403
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Lycopene in the Treatment of Oral Submucous Fibrosis: A Meta-analysis of Randomized Controlled Trials.
Guo J; Xie H; Wu H; Liang M
J Evid Based Dent Pract; 2020 Dec; 20(4):101471. PubMed ID: 33303091
[TBL] [Abstract][Full Text] [Related]
14. Interventions for the management of oral submucous fibrosis.
Fedorowicz Z; Chan Shih-Yen E; Dorri M; Nasser M; Newton T; Shi L
Cochrane Database Syst Rev; 2008 Oct; (4):CD007156. PubMed ID: 18843745
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical tulsi (
Biswas D; Naik Z; Kumar SL; Patil N; Bagewadi A
Indian J Dent Res; 2022; 33(2):146-151. PubMed ID: 36254950
[TBL] [Abstract][Full Text] [Related]
16. Aloe vera in the treatment for oral submucous fibrosis - a preliminary study.
Sudarshan R; Annigeri RG; Sree Vijayabala G
J Oral Pathol Med; 2012 Nov; 41(10):755-61. PubMed ID: 22650317
[TBL] [Abstract][Full Text] [Related]
17. Long-term effectiveness of lycopene in the management of oral submucous fibrosis (OSMF): A 3-years follow-up study.
Arakeri G; Patil S; Maddur N; Rao Us V; Subash A; Patil S; Gao S; Brennan PA
J Oral Pathol Med; 2020 Sep; 49(8):803-808. PubMed ID: 32652683
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant treatments in patients with oral submucous fibrosis: A systematic review.
Pérez-Leal M; Lanciano F; Flacco N; Estornut C; Carceller MC
J Oral Pathol Med; 2024 Jan; 53(1):31-41. PubMed ID: 38155549
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline - A Novel Adjunct in the Management of Patients with Oral Submucous Fibrosis in Terai Population of Nepal: A Prospective Case Control Study.
Wazir SS; Srivastava R
Mymensingh Med J; 2022 Oct; 31(4):1170-1178. PubMed ID: 36189568
[TBL] [Abstract][Full Text] [Related]
20. Versatility of nasolabial flaps for the management of severe trismus in oral submucous fibrosis.
Balaji SM
Indian J Dent Res; 2016; 27(5):492-497. PubMed ID: 27966506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
